These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
473 related articles for article (PubMed ID: 15906137)
1. Anal carcinomas in HIV-positive patients: high-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy. Blazy A; Hennequin C; Gornet JM; Furco A; Gérard L; Lémann M; Maylin C Dis Colon Rectum; 2005 Jun; 48(6):1176-81. PubMed ID: 15906137 [TBL] [Abstract][Full Text] [Related]
2. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy. Wexler A; Berson AM; Goldstone SE; Waltzman R; Penzer J; Maisonet OG; McDermott B; Rescigno J Dis Colon Rectum; 2008 Jan; 51(1):73-81. PubMed ID: 18066626 [TBL] [Abstract][Full Text] [Related]
3. Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for invasive anal carcinoma in human immunodeficiency virus-positive patients receiving highly active antiretroviral therapy. Fraunholz I; Weiss C; Eberlein K; Haberl A; Rödel C Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1425-32. PubMed ID: 19744801 [TBL] [Abstract][Full Text] [Related]
4. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)]. Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148 [TBL] [Abstract][Full Text] [Related]
5. HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy. Oehler-Jänne C; Huguet F; Provencher S; Seifert B; Negretti L; Riener MO; Bonet M; Allal AS; Ciernik IF J Clin Oncol; 2008 May; 26(15):2550-7. PubMed ID: 18427149 [TBL] [Abstract][Full Text] [Related]
6. Long-term effects of chemoradiotherapy for anal cancer in patients with HIV infection: oncological outcomes, immunological status, and the clinical course of the HIV disease. Fraunholz IB; Haberl A; Klauke S; Gute P; Rödel CM Dis Colon Rectum; 2014 Apr; 57(4):423-31. PubMed ID: 24608297 [TBL] [Abstract][Full Text] [Related]
11. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. Salama JK; Mell LK; Schomas DA; Miller RC; Devisetty K; Jani AB; Mundt AJ; Roeske JC; Liauw SL; Chmura SJ J Clin Oncol; 2007 Oct; 25(29):4581-6. PubMed ID: 17925552 [TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma. Finnegan V; Parsons JT; Greene BD; Sharma V Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443 [TBL] [Abstract][Full Text] [Related]
13. [A case of squamous cell carcinoma of the anal cancer with associated human immunodeficiency virus]. Sueda K; Ikenaga M; Miyazaki M; Yasui M; Mishima H; Tsujie M; Omiya H; Miyamoto A; Hirao M; Takami K; Fujitani K; Nakamori S; Yoshida K; Tsujinaka T Gan To Kagaku Ryoho; 2010 Nov; 37(12):2656-8. PubMed ID: 21224670 [TBL] [Abstract][Full Text] [Related]
14. Salvage surgery for residual primary and locally recurrent anal squamous cell carcinoma after chemoradiotherapy in HIV-positive individuals. Cunin L; Alfa-Wali M; Turner J; Bower M; Ion L; Allen-Mersh T Ann Surg Oncol; 2014 Feb; 21(2):527-32. PubMed ID: 24242676 [TBL] [Abstract][Full Text] [Related]
15. Anal carcinoma or "just hemorrhoids"? Winburn GB Am Surg; 2001 Nov; 67(11):1048-58. PubMed ID: 11730221 [TBL] [Abstract][Full Text] [Related]
17. Involved-field, low-dose chemoradiotherapy for early-stage anal carcinoma. Hatfield P; Cooper R; Sebag-Montefiore D Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):419-24. PubMed ID: 17919842 [TBL] [Abstract][Full Text] [Related]
18. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related]
19. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients. Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058 [TBL] [Abstract][Full Text] [Related]
20. Concomitant low-dose cisplatin and three-dimensional conformal radiotherapy for locally advanced squamous cell carcinoma of the head and neck: Analysis of survival and toxicity. Lau H; Brar S; Hao D; MacKinnon J; Yee D; Gluck S Head Neck; 2006 Mar; 28(3):189-96. PubMed ID: 16265658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]